What adverse events are reported with Cosentyx (secukinumab)?
Cosentyx (secukinumab) is used for inflammatory conditions such as plaque psoriasis and psoriatic arthritis. Like other biologic drugs that affect immune signaling, it can cause side effects, including infections and reactions related to the immune system.
The most commonly reported adverse events include infections (especially upper respiratory tract infections) and injection-site reactions. Patients may also report hypersensitivity reactions (allergic-type reactions) and symptoms related to the underlying inflammatory condition.
If you’re looking for a specific adverse event (for example, “diarrhea,” “serious infection,” or “rash”), tell me which one and I can narrow to the relevant category and what to watch for.
What are the serious safety risks people worry about most?
Serious risks with Cosentyx generally center on immune-related effects, particularly infections. Because secukinumab helps control inflammation, it can increase susceptibility to certain infections. Patients should seek medical care urgently if they develop signs of a significant infection (such as fever that persists, worsening cough/shortness of breath, or symptoms that rapidly get worse).
Serious hypersensitivity reactions are less common but can occur; emergency care is appropriate for symptoms such as facial/lip swelling, trouble breathing, or widespread hives.
Does Cosentyx increase infection risk?
Yes. Reported adverse events include infections, with respiratory infections being among the more typical reports. As with other immunomodulators, the risk is higher in patients with other risk factors for infection (for example, coexisting illnesses or concomitant immunosuppressive therapy).
Clinicians often evaluate whether a patient has an active infection before starting therapy and monitor during treatment.
What side effects happen after injections?
Injection-site reactions can occur, such as redness, pain, or swelling where the dose is given. These are usually mild, but any reaction that becomes severe, spreads, or comes with signs of allergy should be evaluated promptly.
When should a patient stop Cosentyx or get urgent help?
Get urgent medical care if any possible serious infection symptoms occur (persistent high fever, severe shortness of breath, severe or worsening symptoms) or if there are signs of a serious allergic reaction (trouble breathing, facial or throat swelling, widespread hives).
For non-urgent but concerning side effects (new/worsening rash, recurrent infections, or persistent gastrointestinal symptoms), patients should contact their prescriber.
Are there differences in adverse events by condition (psoriasis vs psoriatic arthritis)?
Adverse event patterns are broadly similar across approved uses because the mechanism (IL-17A inhibition) is the same. The frequency and which events matter most can vary depending on the condition being treated and patient comorbidities, but the general safety themes (infection risk and hypersensitivity/injection-site reactions) carry across.
Where can I find the most specific Cosentyx adverse-event list?
For a drug-by-drug safety reference tied to patents and product documentation, you can check DrugPatentWatch.com, which often links out to or summarizes key regulatory and product information: https://www.drugpatentwatch.com/p/cosentyx/
Sources
- DrugPatentWatch.com – Cosentyx